A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.
Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.
Empirical data and humans’ biased interpretations can only get so far in truly understanding life at the microscale.
Vaginal birth leads to changes in the development of offsprings’ microbiomes not seen among mice born via C-section, which researchers suspect might contribute to the weight differences.
Combined transcription and genome data from multiple tissues in hundreds of human donors reveal links between genotype and gene expression across the body.
Tissue recipients were treated as “guinea pigs,” says investigation leader.
Mice receiving the treatment produced their own monoclonal antibodies and survived infection with the life-threatening pathogen Pseudomonas aeruginosa.
The award in Physiology or Medicine goes to chronobiologists Jeffrey Hall, Michael Rosbash, and Michael Young.
French revolutionary Jean-Paul Marat took on many roles over the course of his life, including physician and scientist.
After implantation, the tissue developed blood vessels and became integrated into neuronal networks in the animals’ brains.
The nationwide experiment will initially include around 100,000 volunteers.
The 20-year project calls into question the conventional wisdom about the role plants will play in mitigating future climate change.
The US Senate narrowly approved the politician, who does not have a science background.
© 1986-2018 The Scientist
